Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments on thromboxane and prostacyclin modulators part I: thromboxane modulators.

Jean-Michel Dogné1, Xavier de Leval, Julien Hanson

  • 1Natural and Synthetic Drug Research Center, Medicinal Chemistry, University of Liège, 1, av. de l'Hôpital, B-4000 Liège, Belgium. Jean-Michel.Dogne@ulg.ac.be

Current Medicinal Chemistry
|May 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review.

Translational stroke research·2026
Same author

Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration.

Chemical science·2026
Same author

A cross-sectional analysis of multidimensional clinical profiles of older adults engaged in structured post-ICU follow-up: age is not the whole story.

European geriatric medicine·2026
Same author

A photocleavable peptidic Ru(ii) mass-tag enabling targeted DESI and MALDI mass spectrometry imaging in cancer tissues.

Chemical science·2026
Same author

Tetrazolylidene-Stabilized Gold(I) Complexes: Synthesis and Evaluation of Anticancer Activity <i>In Vitro</i>.

Inorganic chemistry·2026
Same author

LIFE-UP Day audit to monitor implementation of post-intensive care syndrome prevention practices: a multicentre cross-sectional study in Belgian intensive care units.

BMJ open·2026

Arachidonic acid metabolites, like thromboxane A(2) (TXA(2)), are key in cardiovascular and inflammatory diseases. New thromboxane modulators offer novel therapeutic strategies by combining TXA(2) antagonism with other activities.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Arachidonic acid (AA) metabolites are implicated in cardiovascular, pulmonary, inflammatory, and thromboembolic diseases.
  • Thromboxane A(2) (TXA(2)), a potent inducer of platelet aggregation and vasoconstriction, plays a crucial role in various pathophysiological states.
  • Diseases linked to TXA(2) include asthma, myocardial ischemia, pulmonary hypertension, and thromboembolic disorders.

Purpose of the Study:

  • To review recently described thromboxane modulators.
  • To discuss these modulators from pharmacological and chemical perspectives.
  • To highlight novel therapeutic strategies targeting TXA(2) pathways.

Main Methods:

  • Literature review of scientific publications and clinical trial data.

Related Experiment Videos

  • Analysis of pharmacological activities and chemical structures of thromboxane modulators.
  • Focus on compounds with combined TXA(2) antagonism and other pharmacological properties.

    • Main Results:

    • Development of TXA(2) receptor antagonists, thromboxane synthase inhibitors, and dual-acting drugs since the 1980s.
    • Several compounds are marketed, with others in clinical evaluation.
    • Emerging interest in thromboxane modulators combining TXA(2) antagonism with activities like PAF antagonism, angiotensin II antagonism, or 5-LOX inhibition.

    Conclusions:

    • Thromboxane modulators represent a significant area of pharmaceutical research and development.
    • Combined pharmacological activities offer potential for improved therapeutic efficacy in complex diseases.
    • Further investigation into these novel agents is warranted for clinical application.